Effects of first-generation antipsychotics versus second-generation antipsychotics on quality of life in schizophrenia: a double-blind, randomised study-Reference-Cited by-同舟云学术

Effects of first-generation antipsychotics versus second-generation antipsychotics on quality of life in schizophrenia: a double-blind, randomised study

Published:2016-08 Issue:8 Volume:3 Page:717-729
ISSN:2215-0366
Container-title:The Lancet Psychiatry
language:en
Short-container-title:The Lancet Psychiatry

Author:

Gründer Gerhard,Heinze Martin,Cordes Joachim,Mühlbauer Bernd,Juckel Georg,Schulz Constanze,Rüther Eckart,Timm Jürgen

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference39 articles.

1. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine;Kane;Arch Gen Psychiatry,1988

2. The ‘atypicality’ of antipsychotics: a concept re-examined and re-defined;Gründer;Nat Rev Drug Discov,2009

3. A meta-analysis of the efficacy of second-generation antipsychotics;Davis;Arch Gen Psychiatry,2003

4. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis;Leucht;Lancet,2009

5. Second-generation antipsychotics for schizophrenia: can we resolve the conflict?;Leucht;Psychol Med,2009

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Effectiveness, Economic, and Humanistic Outcomes of Selected Oral Antipsychotics in Patients with Schizophrenia: A Systematic Review Evaluating Global Evidence;ClinicoEconomics and Outcomes Research;2024-09

2. Symptomatic remission and its associated factors among patients with schizophrenia on risperidone or olanzapine at Amanuel mental specialized hospital, Addis Ababa, Ethiopia;Middle East Current Psychiatry;2024-07-05

3. Haloperidol (oral) versus olanzapine (oral) for people with schizophrenia and schizophrenia-spectrum disorders;Cochrane Database of Systematic Reviews;2024-07-03

4. A review on side effect management of second-generation antipsychotics to treat schizophrenia: a drug safety perspective;Expert Opinion on Drug Safety;2024-05-06

5. Evaluating the 6-month formulation of paliperidone palmitate: a twice-yearly injectable treatment for schizophrenia in adults;Expert Review of Neurotherapeutics;2024-03-06